Discussion about this post

User's avatar
ROLAND GRAD's avatar

In clinical practice, looking for (and finding) prostate cancer is not a challenge. Having a meaningful conversation about life expectancy can be.

Expand full comment
dlnevins's avatar

I am hoping that molecular studies will eventually help us better distinguish between prostatic adenocarcinomas that have little metastatic potential from those which have high metastatic potential. Patient age and Gleason Score/Grade Group, while helpful, don't quite get us there.

Expand full comment
1 more comment...

No posts